Cargando…
Lipid metabolism in autoimmune rheumatic disease: implications for modern and conventional therapies
Suppressing inflammation has been the primary focus of therapies in autoimmune rheumatic diseases (AIRDs), including rheumatoid arthritis and systemic lupus erythematosus. However, conventional therapies with low target specificity can have effects on cell metabolism that are less predictable. A key...
Autores principales: | Robinson, George, Pineda-Torra, Ines, Ciurtin, Coziana, Jury, Elizabeth C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8759788/ https://www.ncbi.nlm.nih.gov/pubmed/35040437 http://dx.doi.org/10.1172/JCI148552 |
Ejemplares similares
-
Challenges in Implementing Cardiovascular Risk Scores for Assessment of Young People With Childhood-Onset Autoimmune Rheumatic Conditions
por: Ciurtin, Coziana, et al.
Publicado: (2022) -
Sex Differences in Lipid Metabolism: Implications for Systemic Lupus Erythematosus and Cardiovascular Disease Risk
por: Robinson, George A., et al.
Publicado: (2022) -
Predicting long-term cardiometabolic risk: Do childhood metabolomic signatures hold the key?
por: Robinson, George A, et al.
Publicado: (2021) -
CD8+ T-Cells in Juvenile-Onset SLE: From Pathogenesis to Comorbidities
por: Ciurtin, Coziana, et al.
Publicado: (2022) -
Investigating sex differences in T regulatory cells from cisgender and transgender healthy individuals and patients with autoimmune inflammatory disease: a cross-sectional study
por: Robinson, George A, et al.
Publicado: (2022)